| |
|
|
|
Tenax Therapeutics Inc.  
|
|
5.7484 0.008 (0%) |
09-21 09:30 |
|
Open: |
5.75 |
Pre close: |
5.74 |
Target:
|
6.95 
|
|
High: |
5.75 |
Low: |
5.7484 |
Resistance:
|
5.95
6.95
|
|
Volume: |
608 |
Market Cap: |
8M |
Support:
|
5.36
5.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.25
|
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
5.37 |
Signal(12,26,9): |
-0.19 |
|
MA(100): |
6.07  |
Stochastic Oscillator |
%K(14,3):
|
38.95 |
|
MA(250): |
7.02 |
%D(3): |
24.33 |
|
Average Volume(K) |
3-Month: |
813
|
52-Week |
High:
|
12.63 |
|
10-Days: |
763 |
Low: |
4.41 |
|
RSI |
RSI(14):
|
54.65 |
Change(%): |
-26.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-63.4 |
Shares Out. (M) |
1.47 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-54.2 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.10 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
97 |
|
Book Value (p.s.) |
1.200 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.25 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.39 |
P/CF |
-1.60 |
|
|
|
|
|
|
